Latest AusBiotech News | Page 14

CSL’s new headquarters will be home to biotech incubator
Member feedback sought on mandatory reporting of adverse events
Call for AusMedtech 2022 session submissions
Telix Pharmaceuticals says first Australian patient doses in global study
AusBiotech highlights cell and gene therapy opportunity to Senate Inquiry
Nirtek begins R&D collaboration with TTRA funding support
AusBiotech calls for feedback on National One Stop Shop for clinical trials
Winner of 2021’s Prime Minister’s Prize for Innovation congratulated
Mr Geoffrey Kempler announced as new AusBiotech Chair
TGA approves Telix Pharmaceuticals’ Illuccix for prostate cancer
Decadal Biotech Blueprint opens for sector-wide consultation
New strategy shot in arm for medical research and innovation
Rhinomed announces details of new trial for Rhinoswab
Life sciences’ highest achievers awarded with prestigious Industry Excellence Awards
Final ‘foundation stones’ set for future of Australian regenerative medicine
Australia’s biggest week in biotech begins
Australia’s premier life sciences conferences celebrate and champion sector
Australian businesses invited to advance future of healthcare technologies in Medtronic challenge
Hearing company Hemideina completes successful capital raise
Proposal to amend definitions of GM for food classifications
Late-stage trial for Dimerix’s investigative Covid treatment
Voluntary standardised IP framework supported
IDT announces deal with Monash to produce mRNA vaccine for trial
Bright ideas sought to keep our country disease and pest free
CV-19 vaccine designer joins AusBiotech 2021 line-up
NSW’s first trade statement aims to double exports by 2031
Global Pipeline Tracker provides view of global pipeline and possible cell and gene therapies for Australia
Standardised agreements proposed to support commercialisation
EnGeneIC launches trial of nano cellular Covid vaccine
Cynata Therapeutics announces publication of new paper
Indian regulator approves study of Dimerix’s DMX-200 in Covid
EOI sought for new Cell and Gene Catalyst
New research shows drug repurposing is no ‘quick-fix’ in race to treat Covid
Japanese patent for Imugene’s HER-Vaxx immunotherapy
Manufacturing opportunities in cell and gene therapies highlighted in Inquiry submission
SUDA Pharmaceuticals announces ‘firm commitments’ on capital raise
US FDA grants emergency authorisation to Ellume’s COVID-19 test
AusBiotech office closure
NSW Medical Devices Fund opens
Europe grants Antisense’s ATL1102 orphan designation
Save date: AusMedtech 2021
Immutep updates on AIPAC breast cancer study and announces new trial
Queensland government back Ellume manufacturing expansion
Shaping industry’s future starts with goals
New guidance on regulatory changes for custom-made medical devices
TGA grants priority review for Telix Pharmaceuticals’ TLX591-CDx
Noxopharm completes $23m share placement
Global manufacturing survey invites Australia’s views